中國秦發(00866.HK)公佈2019年業績:年度純利達8140萬元,毛利率增至14.5%
格隆匯3月31日丨中國秦發(00866.HK)公佈,截至2019年12月31日止全年,實現收益28.00億元人民幣(單位下同);公司權益持有人應占溢利8140萬元;基本每股盈利3.1分,不派息。
2019年的毛利率為14.5%。與2018年10.7%的毛利率相比,毛利率增加乃主要由於銷售成本降低。於2019年,貿易量主要源於集團之煤礦生產,而生產成本遠低於向外部供應商的採購成本。
2019年煤炭經營及貿易量以及商業煤產量分別為約760萬噸及652萬噸,較2018年減少25.2%及增加45.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.